Metabolic pathways regulating hepatic glucose output and insulin sensitivity

Metabolic pathways regulating hepatic glucose output and insulin sensitivity encompass the integrated biochemical processes in the liver that maintain systemic glucose levels. The liver maintains glucose homeostasis by balancing glucose uptake and storage as glycogen with the production of glucose through gluconeogenesis and glycogenolysis. These processes are primarily regulated by the opposing actions of insulin, which suppresses glucose output, and glucagon, which promotes it (Source: NIH, StatPearls). In healthy individuals, insulin effectively inhibits hepatic glucose production; however, in insulin-resistant states such as type 2 diabetes, this suppression fails, leading to excessive glucose release and fasting hyperglycemia. Therapeutic interventions often target specific molecular nodes within these pathways, such as the insulin receptor or AMPK, to restore metabolic control and improve insulin sensitivity (Source: PubMed, UniProt).

Other names

Hepatic glucose metabolismInsulin signaling in the liverRegulation of gluconeogenesis and glycogenolysisHepatic insulin sensitivity pathways

Drugs modulate these pathways by inhibiting key gluconeogenic enzymes (e.g., PEPCK, G6Pase), activating energy-sensing regulators like AMP-activated protein kinase (AMPK), or enhancing insulin receptor signaling to suppress endogenous glucose production (Source: PubMed, StatPearls).